title: River blindness: a success story under threat?
authors.affiliation: Department of Infectious Disease Epidemiology, Imperial College of Science, Technology and Medicine, London, United Kingdom. m.basanez@imperial.ac.uk
authors.forename: María-Gloria
authors.initials: MG
authors.lastname: Basáñez
authors.forename: Sébastien D S
authors.initials: SD
authors.lastname: Pion
authors.forename: Thomas S
authors.initials: TS
authors.lastname: Churcher
authors.forename: Lutz P
authors.initials: LP
authors.lastname: Breitling
authors.forename: Mark P
authors.initials: MP
authors.lastname: Little
authors.forename: Michel
authors.initials: M
authors.lastname: Boussinesq
mesh_terms: D000349:Africa / Q000453:epidemiology; D000977:Antiparasitic Agents / Q000627:therapeutic use*; D003153:Community Health Services; D017281:Cost of Illness; D003906:Developing Countries / Q000706:statistics & numerical data; D014943:Global Health; D017048:Health Care Costs; D006801:Humans; D007391:International Cooperation; D007559:Ivermectin / Q000627:therapeutic use*; D015827:Onchocerciasis, Ocular / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D012959:Socioeconomic Factors
chemical_list: D000977:Antiparasitic Agents; D007559:Ivermectin